The Rheumatoid Arthritis Treatment Market is at a significant crossroads, characterized by rapid advancements in therapeutics and an increasing demand driven by the global rise in RA cases. This chronic inflammatory disorder affects millions worldwide, leading to joint damage and severe pain, underscoring the need for effective treatments.
The advent of new classes of drugs, particularly Biologic DMARDs and Janus Kinase (JAK) inhibitors, has revolutionized the ... Read more
